Inventor
ZHU XIUWEN
US23 patents
⚠️ This page may combine multiple inventors who share the name “ZHU XIUWEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
13 patentsUS9126932B2Sep 8, 2015
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC17 citations91
US9108969B2Aug 18, 2015
Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC6 citations84
US10632134B2Apr 28, 2020
Cannabinoid receptor modulators
ARENA PHARM INC5 citations83
US9867822B2Jan 16, 2018
Cannabinoid receptor modulators
ARENA PHARM INC7 citations83
US9522133B2Dec 20, 2016
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC9 citations83
US9492447B2Nov 15, 2016
Cannabinoid receptor modulators
ARENA PHARM INC9 citations83
US11771695B2Oct 3, 2023
Cannabinoid receptor modulators
ARENA PHARM INC4 citations74
US11214548B2Jan 4, 2022
Cannabinoid receptor modulators
ARENA PHARM INC3 citations72
US10392390B2Aug 27, 2019
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC6 citations72
US10836764B2Nov 17, 2020
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC2 citations71
US12109219B2Oct 8, 2024
Cannabinoid receptor modulators
ARENA PHARM INC0 citations62
US11746091B2Sep 5, 2023
Cannabinoid receptor modulators
ARENA PHARM INC0 citations62
US11608339B2Mar 21, 2023
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC0 citations60
JONES ROBERT M
4 patentsUS8778950B2Jul 15, 2014
Cannabinoid receptor modulators
JONES ROBERT M21 citations92
US8580841B2Nov 12, 2013
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
JONES ROBERT M21 citations92
US8415484B2Apr 9, 2013
Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
JONES ROBERT M29 citations92
US9944606B2Apr 17, 2018
Cannabinoid receptor modulators
JONES ROBERT M3 citations72